nintedanib mode of action

Boehringer Ingelheim launches comprehensive support resources for people with idiopathic pulmonary fibrosis RIDGEFIELD, Conn., October 20, 2014 – Boehringer Ingelheim Pharmaceuticals, Inc. Read More